Phase 4Completed

Investigating Different Anticoagulants for Renal Replacement Therapy (RICH)

Regional Citrate Versus Systemic Heparin Anticoagulation for Continuous Renal Replacement Therapy in Critically Ill Patients With Acute Kidney Injury

Sponsor
University Hospital Muenster (Academic or other)
Enrollment
638 enrolled
Conditions
Acute Kidney Injury
Interventions
Heparin; Citrate
Ages
adults, older adults
Registry
NCT02669589, EUCTR2014-004854-33

Full record on ClinicalTrials.gov

From the registry

The aim of this study is to evaluate the effect of regional citrate anticoagulation within the scope of continuous renal replacement (CRRT) in critically ill patients with acute kidney injury (AKI) on filter life span and 90-day all cause mortality.

Primary outcomes

  • CRRT-filter life span in hours
  • Overall survival in a 90day follow-up period

History

  1. Last registry update

  2. Study completion

  3. Primary completion

  4. Started

  5. Registered

Papers citing this trial